Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

ClinicalTrials.gov ID: NCT00907387

Public ClinicalTrials.gov record NCT00907387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Randomized, Parallel-Group, Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Safety and Efficacy of RT001, a Botulinum Toxin Type A Topical Gel, for the Treatment Lateral Canthal Lines in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults and duration of effect.

Study identification

NCT ID
NCT00907387
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
72 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
30 Years to 60 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Jan 17, 2014

2009

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Total Skin & Beauty Dermatology Center Birmingham Alabama 35205 —
Richard G. Glogau, Inc. San Francisco California 94117 —
Dermatology Research Institute, LLC Coral Gables Florida 33146 —
SkinCare Physicians, Inc. Chestnut Hill Massachusetts 02467 —
Skin Specialists, PC Omaha Nebraska 68144 —
Head and Neck Surgical Group New York New York 10019 —
Aesthetic Plastic Surgery New York New York 10065 —
Dermatology Surgery and Laser Center White Plains New York 10604 —
Suzanne Bruce & Associates / The Center for Skin Research Houston Texas 77056 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00907387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00907387 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →